ED50 of Esketamine for Laser Treatment in Children

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-03-27

Study Completion Date

2025-04-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

There is limited research on the combined use of esketamine and alfentanil for anesthesia during facial laser treatment in pediatric patients, and the effective dosage of esketamine for inhibiting body movement remains unclear. We explore the effective dose of esketamine combined with alfentanil for the inhibition of body movement during facial laser treatment in pediatric patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The ED95 of Single Intravenous Bolus Remimazolam Besylate in Pediatric Patients During General Anesthesia Induction

NCT06061159

Pediatric ED95 Sedation +1 more

COMPLETED PHASE4

ED90 of Remimazolam Anesthesia Induction in Painless Bidirectional Endoscopy in Children

NCT06121609

Bidirectional Endoscopy

COMPLETED NA

Ketamine Tolerance in Children After Repeated Administrations During Radiotherapy Sessions

NCT02512055

Conscious Sedation Failure During Procedure

COMPLETED PHASE4

Study to Evaluate the Optimal Dose of Remifentanil During MRI of the Heart Under General Anaesthesia

NCT02481791

Children Heart Diseases Anaesthesia +1 more

UNKNOWN PHASE3

Dose of Remi in Children

NCT05990673

Anesthesia

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anesthesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SEQUENTIAL

The Biased coin method is used

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Esketamine will be prepared by an investigator who is not involved in anesthesia and outcome assessment. For all participants, esketamine will be diluted to the same volume.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

esketamine

esketamine will be given intravenously

Group Type EXPERIMENTAL

Esketamine

Intervention Type DRUG

esketamine will be given intravenously

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Esketamine

esketamine will be given intravenously

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

intravenous esketamine

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age between 3 years and 12 years old
* patients scheduled for laser treatment of facial lesion

Exclusion Criteria

* patients with airway infection during the last 1 month
* patients with cardiac or pulmonary disorder
* patients with hepatic or renal disfunction
* patients with neurologic or psychiatric disorder

Minimum Eligible Age

3 Years

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No